Syncom Form Peer Comparison

NSE: SYNCOMF | BSE: 524470

₹20.01

₹-0.39 (-1.91%)

As on 23-Sep-2026IST

Market cap

₹1,883 Cr

Revenue (TTM)

₹498 Cr

P/E Ratio

P/B Ratio

4.3

Div. Yield

0 %

Edit

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	1,883	21,217	20,284	17,618	18,377
Revenue (₹ Cr)	498	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	85.53	678.07	273.51	666.92	735.15
Net Margin (%)	16.11	28.10	16.19	20.60	26.88
RoE (%)	21.56	19.73	11.15	18.75	19.16
Price to Earnings	22.01	31.89	68.22	27.36	25.00
Price-To-Book	4.28	5.78	7.55	4.37	4.17

Income Statement (₹ Cr)

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	494.69	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	527.45	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	407.44	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	87.25	796.58	478.55	1,139.61	941.63
Depreciation	6.73	78.10	126.01	281.06	57.58
EBIT	80.52	718.48	352.55	858.55	884.05
Interest	1.10	0.88	52.11	190.64	7.69
Other Income	32.76	125.96	7.37	7.45	165.62
Exceptional Items	0.00	0.00	12.16	-17.24	-49.16
Profit before Tax	112.18	843.56	319.96	658.12	992.82
Provision for Tax	27.31	165.49	46.45	-8.80	257.67
Profit after Tax	84.87	678.07	273.51	666.92	735.15

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	412.30	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	0.00	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	15.13	28.74	266.35	1,392.75	91.50
Current Liabilities	101.83	385.94	848.06	2,077.10	627.48
Total Liabilities	--	3,207.85	3,310.68	6,865.52	4,911.11

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	186.08	1,291.22	2,525.44	5,617.77	770.28
Current Assets	326.03	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	--	3,207.85	3,310.68	6,865.52	4,911.11
Total Debt*	--	0.55	586.37	2,421.66	2.50
Net Current Assets	224.21	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	--	0.64	76.22	51.96	363.79

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	--	432.37	132.27	1,065.01	659.75
Cash Flow from Investing Activities	--	-334.73	-199.13	-79.97	-71.34
Cash from Financing Activities	--	-38.32	62.65	-881.32	-205.34
Net Cash Inflow / Outflow	--	59.32	-4.21	103.72	383.07

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	--	26.22	6.95	13.59	26.21
ROE (%)	21.52	19.73	11.15	18.75	19.16
ROA (%)	18.08	18.69	7.80	9.26	14.95
EBIT Margin (%)	16.28	31.41	20.95	26.58	34.40
Net Margin (%)	16.09	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	0.23	15.01	27.91	9.59	10.69
EBIT Growth (%)	47.62	18.45	58.32	16.84	24.14
Net Profit Growth (%)	48.97	19.61	149.56	62.68	-9.09
EPS Growth (%)	49.07	17.73	-3.57	67.41	14.40
Book Value Growth (%)	--	23.77	30.63	10.19	17.30

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	22.18	31.89	72.37	26.67	23.82
Price / Book Value	4.31	5.78	7.55	4.37	4.17
Dividend Yield (%)	0.00	0.29	0.06	0.00	1.87
EV/EBITDA	20.60	25.37	43.67	17.43	16.22
Market Cap (₹ Cr)	--	15,219.80	6,484.12	19,292.77	18,318.10

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.00	0.00	0.07	0.24	0.00
Short term debt to equity ratio	--	0.00	0.13	0.14	0.00
Current Ratio	3.20	6.70	1.31	0.74	6.06
Quick Ratio	2.58	5.59	0.88	0.53	5.31
Interest Coverage	103.26	959.59	7.14	4.45	130.11

	Syncom Form	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	21.75	36.10	30.84	21.07	7.07
Asset Turnover	1.05	0.63	0.48	0.45	0.52
Receivable days	--	110.70	118.15	54.06	29.10
Inventory Days	--	65.86	98.29	32.16	69.53
Payable days	--	105.88	128.16	140.91	76.77
Cash Conversion Cycle	--	70.68	88.28	-54.69	21.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.